美国 · SEC FORM 4
OWENS & MINOR INC/VA/
OMI · NYSE · CIK 0000075252 · Healthcare
内部人信号
当前没有活跃买入信号
0 qualifying P purchase groups
当前 180 天评分窗口
11 同一窗口内观察到的 Form 4 交易行
0 sales · 11 期权、代扣税、授予、赠与或其他交易行
最近一次合资格买入2025-08-14 · COLISEUM CAPITAL PARTNERS, L.P.; Coliseum Capital Management, LLC; Coliseum Capital, LLC; Gray Adam; Shackelton Christopher S · $2.6M
为什么没有活跃信号？
买入活动无
近期买入无
近期卖出无
买入信号状态未激活
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
Cluster未计算
买入规模未计算
角色未计算
近期性未计算
确信度未计算
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
AprMayJunJulAugSepOct
Galloway Heath HEVP,General Counsel & CorpSecy
○○
Leon Jonathan AEVP & CFO
○○
Gardner-Smith KennethDirector
○○
Pesicka Edward APresident & CEO
○
Bernocchi Perry AEVP, Chief Operating Officer
○
Kline Teresa L.Director
○
● 买入▼ 卖出○ 其他
Showing the six most active owners; 2 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
暂无已记录的活跃信号快照
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2025-08-14 · COLISEUM CAPITAL PARTNERS, L.P.; Coliseum Capital Management, LLC; Coliseum Capital, LLC; Gray Adam; Shackelton Christopher S.
近期 Form 4 活动
0买入
0卖出
19其他 Form 4 交易行
19SEC 申报 · 365天
买入0 qualifying P line(s) · 180 days
卖出0 sale line(s) · 仅供背景
其他11 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not assessed
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
FINRA 报告中没有该股票代码的空头余额。
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2025-08-14 | COLISEUM CAPITAL PARTNERS, L.P.; Coliseum Capital Management, LLC; Coliseum Capital, LLC; Gray Adam; Shackelton Christopher S | 买入 (P) | Common Stock | 492,852 | USD 5.31 | USD 2,617,044 | SEC 申报 ↗ |
| 2025-08-13 | COLISEUM CAPITAL PARTNERS, L.P.; Coliseum Capital Management, LLC; Coliseum Capital, LLC; Gray Adam; Shackelton Christopher S | 买入 (P) | Common Stock | 325,000 | USD 5.46 | USD 1,774,500 | SEC 申报 ↗ |
| 2025-08-12 | COLISEUM CAPITAL PARTNERS, L.P.; Coliseum Capital Management, LLC; Coliseum Capital, LLC; Gray Adam; Shackelton Christopher S | 买入 (P) | Common Stock, par value $2 per share ("Common Stock") | 720,000 | USD 5.15 | USD 3,708,000 | SEC 申报 ↗ |
| 2025-04-10 | COLISEUM CAPITAL PARTNERS, L.P.; Coliseum Capital Management, LLC; Coliseum Capital, LLC; Gray Adam; Shackelton Christopher S | 买入 (P) | Common Stock | 80,000 | USD 7.19 | USD 575,200 | SEC 申报 ↗ |
| 2025-04-09 | COLISEUM CAPITAL PARTNERS, L.P.; Coliseum Capital Management, LLC; Coliseum Capital, LLC; Gray Adam; Shackelton Christopher S | 买入 (P) | Common Stock | 225,000 | USD 7.39 | USD 1,662,750 | SEC 申报 ↗ |
| 2025-04-08 | COLISEUM CAPITAL PARTNERS, L.P.; Coliseum Capital Management, LLC; Coliseum Capital, LLC; Gray Adam; Shackelton Christopher S | 买入 (P) | Common Stock, par value $2 per share ("Common Stock") | 105,000 | USD 7.96 | USD 835,800 | SEC 申报 ↗ |
| 2025-04-07 | COLISEUM CAPITAL PARTNERS, L.P.; Coliseum Capital Management, LLC; Coliseum Capital, LLC; Gray Adam; Shackelton Christopher S | 买入 (P) | Common Stock | 240,000 | USD 7.84 | USD 1,881,600 | SEC 申报 ↗ |
| 2025-04-04 | COLISEUM CAPITAL PARTNERS, L.P.; Coliseum Capital Management, LLC; Coliseum Capital, LLC; Gray Adam; Shackelton Christopher S | 买入 (P) | Common Stock | 128,356 | USD 8.14 | USD 1,044,818 | SEC 申报 ↗ |
| 2025-04-03 | COLISEUM CAPITAL PARTNERS, L.P.; Coliseum Capital Management, LLC; Coliseum Capital, LLC; Gray Adam; Shackelton Christopher S | 买入 (P) | Common Stock, par value $2 per share ("Common Stock") | 160,000 | USD 8.53 | USD 1,364,800 | SEC 申报 ↗ |
| 2025-03-04 | COLISEUM CAPITAL PARTNERS, L.P.; Coliseum Capital Management, LLC; Coliseum Capital, LLC; Gray Adam; Shackelton Christopher S | 买入 (P) | Common Stock | 800,000 | USD 9.75 | USD 7,800,000 | SEC 申报 ↗ |
| 2025-03-03 | COLISEUM CAPITAL PARTNERS, L.P.; Coliseum Capital Management, LLC; Coliseum Capital, LLC; Gray Adam; Shackelton Christopher S | 买入 (P) | Common Stock | 354,901 | USD 9.19 | USD 3,261,540 | SEC 申报 ↗ |
| 2025-02-28 | COLISEUM CAPITAL PARTNERS, L.P.; Coliseum Capital Management, LLC; Coliseum Capital, LLC; Gray Adam; Shackelton Christopher S | 买入 (P) | Common Stock, par value $2 per share ("Common Stock") | 1,738,511 | USD 9.39 | USD 16,324,618 | SEC 申报 ↗ |
| 2022-10-17 | Henkel Robert J | 买入 (P) | Common Stock | 1,000 | USD 15.68 | USD 15,680 | SEC 申报 ↗ |
| 2022-07-15 | Henkel Robert J | 买入 (P) | Common Stock | 1,000 | USD 31.76 | USD 31,760 | SEC 申报 ↗ |
| 2022-05-02 | Henkel Robert J | 买入 (P) | Common Stock | 2,000 | USD 35.00 | USD 70,000 | SEC 申报 ↗ |
Form 4 申报证据
19 transaction lines in the latest 365-day window; 435 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-05 | Gardner-Smith Kenneth | 奖励／授予 (A) | Common Stock | 283,554 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-23 | Leon Jonathan A | 代扣税 (F) | Common Stock | 4,265 | USD 0.85 | USD 3,625 | SEC 申报 ↗ |
| 2026-05-18 | Galloway Heath H | 代扣税 (F) | Common Stock | 1,822 | USD 2.91 | USD 5,302 | SEC 申报 ↗ |
展开近期 Form 4 证据 (19 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-05 | Gardner-Smith Kenneth | 奖励／授予 (A) | Common Stock | 283,554 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-23 | Leon Jonathan A | 代扣税 (F) | Common Stock | 4,265 | USD 0.85 | USD 3,625 | SEC 申报 ↗ |
| 2026-05-18 | Galloway Heath H | 代扣税 (F) | Common Stock | 1,822 | USD 2.91 | USD 5,302 | SEC 申报 ↗ |
| 2026-05-15 | Pesicka Edward A | 代扣税 (F) | Common Stock | 17,692 | USD 3.04 | USD 53,784 | SEC 申报 ↗ |
| 2026-05-15 | Leon Jonathan A | 代扣税 (F) | Common Stock | 1,770 | USD 3.04 | USD 5,381 | SEC 申报 ↗ |
| 2026-05-15 | Galloway Heath H | 代扣税 (F) | Common Stock | 966 | USD 3.04 | USD 2,937 | SEC 申报 ↗ |
| 2026-05-15 | Bernocchi Perry A | 代扣税 (F) | Common Stock | 7,908 | USD 3.04 | USD 24,040 | SEC 申报 ↗ |
| 2026-05-14 | Kline Teresa L. | 奖励／授予 (A) | Common Stock | 31,191 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-14 | Klemash Stephen W | 奖励／授予 (A) | Common Stock | 31,191 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-14 | Gardner-Smith Kenneth | 奖励／授予 (A) | Common Stock | 31,191 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-14 | Beck Mark A | 奖励／授予 (A) | Common Stock | 31,191 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-20 | Pesicka Edward A | 代扣税 (F) | Common Stock | 58,945 | USD 2.03 | USD 119,658 | SEC 申报 ↗ |
| 2026-03-20 | Leon Jonathan A | 代扣税 (F) | Common Stock | 11,286 | USD 2.03 | USD 22,911 | SEC 申报 ↗ |
| 2026-03-20 | Galloway Heath H | 代扣税 (F) | Common Stock | 9,347 | USD 2.03 | USD 18,974 | SEC 申报 ↗ |
| 2026-03-20 | Bernocchi Perry A | 代扣税 (F) | Common Stock | 20,841 | USD 2.03 | USD 42,307 | SEC 申报 ↗ |
| 2026-03-09 | Leon Jonathan A | 奖励／授予 (A) | Common Stock | 85,067 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-09 | Galloway Heath H | 奖励／授予 (A) | Common Stock | 61,437 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-09 | Bernocchi Perry A | 奖励／授予 (A) | Common Stock | 108,696 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2025-11-19 | Long Andrew G | 赠与 (G) | Common Stock | 47,908 | USD 0.00 | USD 0 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | OMI |
| CIK | 0000075252 |
| 行业 | Healthcare |
| 细分行业 | — Yahoo Finance |
| SEC SIC | 5047 Wholesale-Medical, Dental & Hospital Equipment & Supplies |
| 交易所 | NYSE |
数据覆盖
| 本地 Form 4 历史 | 435 transaction lines from 2020-01-06 to 2026-10-05 27 P purchase lines · 114 S sale lines · 294 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.